Report overview
The global Essential Hypertension Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Calcium Channel Blockers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Essential Hypertension Drugs include Pfizer, Novartis, AstraZeneca, Bayer, Sanofi, Boehringer Ingelheim, Merck, Lupin Pharmaceuticals and Huahai Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
High blood pressure is a common condition that affects the body's arteries. It's also called hypertension. If you have high blood pressure, the force of the blood pushing against the artery walls is consistently too high. The heart has to work harder to pump blood. There are many different high blood pressure medications (antihypertensives) available, each with pros and cons.
This report aims to provide a comprehensive presentation of the global market for Essential Hypertension Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Essential Hypertension Drugs. This report contains market size and forecasts of Essential Hypertension Drugs in global, including the following market information:
Global Essential Hypertension Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Essential Hypertension Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Essential Hypertension Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Essential Hypertension Drugs Market Segment Percentages, by Type, 2023 (%)
Calcium Channel Blockers
ACE Inhibitors
Angiotensin II Receptor Blockers
Beta Blockers
Diuretics
Others
Global Essential Hypertension Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Essential Hypertension Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Essential Hypertension Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Essential Hypertension Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Essential Hypertension Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Essential Hypertension Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
AstraZeneca
Bayer
Sanofi
Boehringer Ingelheim
Merck
Lupin Pharmaceuticals
Huahai Pharmaceutical
Jiangsu Jibeier Pharmaceutical
Tianjin Pharmaceutical Da Ren Tang Group
Chengdu Easton Biopharmaceuticals
Qingdao Huanghai Pharmaceutical
CR Double-Crane
Shanghai Shyndec Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Essential Hypertension Drugs, market overview.
Chapter 2: Global Essential Hypertension Drugs market size in revenue.
Chapter 3: Detailed analysis of Essential Hypertension Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Essential Hypertension Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
